Aspirin has been shown to be as effective as the direct acting oral anticoagulant (DOAC) rivaroxaban as extended prophylaxis against venous thromboembolism (VTE) following hip or knee arthroplasty. In a randomised controlled trial involving 3424 patients who received an initial five days of rivaroxaban prophylaxis, there was no difference in VTE incidence among those randomised ...
Aspirin as good as DOACs for VTE prophylaxis
By Michael Woodhead
23 Feb 2018